All Posts

New Screening Guidelines for Gestational Diabetes

A new recommendation from the U.S. Preventive Services Task Force (USPSTF) advises all women to get screened for gestational diabetes after 24 weeks of pregnancy regardless of whether they have symptoms of the condition. Experts say the number of women developing the condition is on the rise as obesity, older maternal age and other risk factors become increasingly common. Read more.

Diabetes Camp Weekend Events

It’s not too late to sign up for an upcoming Florida Diabetes Camp weekend event! At camp, children improve self-confidence and self-esteem, and learn the social skills of positive interaction that stay with them for a lifetime. What could be better for a child with diabetes? Upcoming dates and locations can be found by clicking here. We look forward to seeing you!

Dining Out: New Calorie and Sodium Woes

Before you plan your next meal away from home, you may want to learn what researchers are learning about sit-down and fast food restaurants which may pose new threats to your waistline and overall health.

Betatrophin May Benefit T2D Patients, study finds

A newly-discovered hormone, betatrophin, has the ability to sharply boost the number of insulin-producing cells in mice according to a new study; a discovery which may someday lead to a treatment for Type 2 diabetes, which accounts for almost 90% of all diabetes cases. Read more.

UF Diabetes Institute Welcomes New Clinical Coordinator

The UF Diabetes Center is pleased to welcome Eleni Polopolus Sheehan, BSN, RN, to our team. Eleni will serve as a clinical research coordinator and work on studies including the T1D Exchange and The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ms. Sheehan left a career in marketing and non-profit development to pursue a career in diabetes research and clinical care. Read more.

Cell Transplants Could Provide Diabetes Cure

Researchers at the University of Minnesota have completed testing on an insulin-transplant technique which delivers pancreatic islet-cells from human donors to type 1 patients. If approved by the FDA, the pilot treatment could revolutionize existing treatment options for T1D patients by helping them remain insulin-free after five years. Read more.

Canine Crusader Makes A World of Difference

Canine crusader 'Nice' the dog and owner Erik Bendl, known as “World Guy” travel the nation promoting diabetes awareness. Learn how their latest journey led them to the University of Florida's Small Animal Hospital to help them continue in their mission.

FDA Approves New OmniPod Insulin Delivery System

Insulet's new OmniPod System, approved by the FDA is 34% smaller, 25% lighter and 16% slimmer. And although it's smaller, it still holds up to 200 units of insulin which can be worn continuously for up to three days. Learn how you can acquire your own.

Diabetes Research at UF

The University of Florida’s Diabetes Center of Excellence is an international leader in type 1 and type 2 diabetes research. Our team is dedicated to understanding the causes of diabetes and investigating therapies to treat and ultimately cure the disease. Learn more about clinical research underway at the UF Diabetes Center of Excellence. We have several studies that we are currently recruiting for.

Diabetes Researchers Present at Postdoc Research Symposium

UF Diabetes Researchers from the Department of Pathology, Immunology, and Laboratory Medicine participated in UF's First Annual Postdoctoral Research Symposium, sponsored by the Office of Postdoctoral Affairs and Office of the Provost. Their work highlights the latest progress being made in the advancement of type 1 diabetes research. Learn more.